The biopharmaceutical industry is uniquely prepared to combat COVID-19.

The Ford government projected a deficit of $20.5 billion for 2020-21.

Prices are almost completely nonexistent for government-provided goods and services.

The lack of innovation in the government sector is rooted in the differences between the incentives and disciplines imposed by customers on the government and private sectors.

Divergences between expected inflation and actual inflation contribute to economic inefficiencies that harm economic growth.

Treatable conditions may turn into more permanent debilitating conditions.

Federal deficit estimates range from $100 billion to $200 billion for fiscal year 2020-21.

The federal debt going into this recession would have been $617.9 billion rather than the expected $713.2 billion.